Clinical Trials in Georgia

Showing 3781-3800 of 19,050 trials

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

NCT02675465

This is an international, multi-center, open-label study designed to evaluate if the co-administration of investigational new drugs ATB200 and AT2221 is safe in adults with Pompe disease.

Pompe Disease

Amicus Therapeutics29 participantsStarted Apr 2016

Phoenix, Arizona, United States • Orange, California, United States • Gainesville, Florida, United States +16 more locations

RECRUITING65 miles

The Myelin Disorders Biorepository Project

NCT03047369

The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.

LeukodystrophyWhite Matter DiseaseLeukoencephalopathies+63 more

Children's Hospital of Philadelphia12,000 participantsStarted Dec 2016

Los Angeles, California, United States • Orange, California, United States • Palo Alto, California, United States +20 more locations

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

The Myelin Disorders Biorepository Project

Find Trials by Condition in Georgia

Minima Stent System Post- Approval Study (PAS)

Assessing Durable Antibody Response to HPV Vaccination

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS